Children Can’t Wait: A Night That Proved Why
CobiCure’s inspiring NYC event brought together experts to accelerate treatments for children with rare diseases. Because every kid deserves care now, not later.
Read more
Advancium Health Network Names Michele Cleary CEO to Drive Next Phase of Pediatric Healthcare Innovation
Advancium Health Network appoints Michele Cleary, PhD, as CEO to advance its mission of faster pediatric treatments and devices for rare diseases through Advancium and CobiCure. Her leadership will fuel key partnerships and urgent progress for affected families.
Read moreUnlocking Stranded Innovation for Children: How CobiCure Is Reimagining Access to Life-Changing Therapies
Aligned with ASGCT's vision for advancing "stranded innovation", CobiCure is rescuing promising but commercially abandoned therapies for children with rare diseases.
Read moreCobiCure Therapeutics Launches to Develop New Medicines for Pediatric Cancers and Rare Diseases
August 7, 2025 | New nonprofit endeavor will focus on accelerating promising therapies that would otherwise be overlooked by traditional biotech funders
Read moreFrankel Foundation Ignites $10 Million Accelerator at CobiCure for Pediatric Clinical Development
July 30, 2025 | Landmark investment establishes dedicated accelerator to fast-track life-saving innovations to accelerate clinical development for pediatric medical devices and therapies for childhood cancer and rare diseases
Read more
